Winning Stock Forecast: Celldex Therapeutics (CLDX) Remarkable Return of 130.93% Over 1 Month

CLDX Winning Stock Forecast

Source: pixnio

Celldex Therapeutics, Inc., incorporated on December 9, 1983, is a bio-pharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. The Company is using the technologies to develop targeted immunotherapeutics consisting of protein-based molecules, such as vaccines, antibodies and antibody-drug conjugates that are used to treat specific types of cancer or other diseases. The Company’s lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic

Read More

DVAX Stock Forecast: Table Is Being Set – Revenue Growth Is On The Way

  The article was written by Amber Zhou, a Financial Analyst at I Know First.

DVAX Stock Forecast

“We believe there’s a great opportunity for Dynavax to contribute to the overall health of the adult population with diabetes”—said Dr. Rob Janssen, chief medical officer of Dynavax.




  • Competitive Edge and Huge Market Potential from Heplisav-B®
  • Market Doubts about Trial Data of Immuno-Oncology Platform
  • Strong Cash Position from Debt Financing
  • Current I Know First Bullish Forecast For DVAX

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Winning Stock Forecast: Omeros Corporation Stock (NASDAQ: OMER) Revitalizes Your Portfolio With 70.31% In 14 Days

Winning Stock Forecast

“We believe that we now have clear paths to accelerated approval for OMS721 in both stem-cell TMA and IgA nephropathy. With breakthrough therapy designations in both of these indications, we look forward to continuing to work closely with FDA and, for stem-cell TMA, we have initiated preparations for a BLA submission”

– Gregory A. Demopulos, M.D., Chairman and CEO of Omeros

Over the 14 days period from May 1st to May 15th, 2018 OMER stock price experienced steep price rise of more than 70%. Taking into account the overall OMER stock performance indicators for the last quarter, it

Read More

Amicus Stock Quick Win By The Algorithm: FOLD Climbs On FDA Decision

Quick Win By The Algorithm

Read The Full Forecast

             Amicus Stock

Myraid Stock Quick Win by the Algorithm: Profitability In Its Genetics

Quick Win by the Algorithm

Read The Full Forecast

Quick Win

I Know First Reviews Weekly Algorithmic Performance: October 2nd, 2016

I Know First Reviews

On October 2nd, 2016, our latest newsletter was sent out to all our I Know First subscribers, which can be found here. Below, find the I Know First Reviews, highlighting the algorithm's performance for this past week. I Know First Reviews

Read The Full Review

Biotech Stocks Based On Big Data: Up to 80.43% Return in 1 Month

Package Name: BioTech Stocks
Forecast Length: 1 Month (10/23/15 – 11/23/15)
I Know First Average: 18.63%

Read The Full Forecast

Biotech Stocks